Back to results
US 2023/0389831 A1Published application
Continuous analyte measurement systems and systems and methods for implanting them
AssigneeAbbott Diabetes Care Inc.
InventorsUdo Hoss, John Charles Mazza, Phu Le
Life of this patent
Estimating the term…
Abstract
Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
Claims16
A method of determining a glucose level, comprising:
- providing glucose monitoring system including
- a data processing unit configured for mounting on a skin surface, the data processing unit including
- one or more processors,
- one or more memories coupled with the one or more processors,
- the one or more memories having a drift profile stored thereon, wherein the drift profile is time dependent,
- an RF transmitter/receiver coupled to the one or more processors, and
- a fixation element comprising an adhesive configured to secure the data processing unit to the skin surface;
- a glucose sensor including
- a proximal portion electrically coupled to the one or more processors of the data processing unit, and
- a distal portion configured to be inserted through the skin surface and in contact with an interstitial fluid,
- wherein the glucose sensor is configured to generate electrical signals indicative of levels of glucose in the interstitial fluid, and the glucose monitoring system does not require user-initiated calibration during a life of the glucose sensor extending between 3 and 14 days;
- causing the glucose sensor to extend through the skin surface such that the distal portion placed in contact with the interstitial fluid;
- receiving a signal from the glucose sensor;
- determining a drift correction factor based on the drift profile;
- determining a glucose level based on the signal from the glucose sensor and the drift correction factor;
- and
- transmitting the glucose level to a receiving device for display to a user.
14 more elements
The method of claim 16, wherein the drift profile accounts for early signal attenuation.
Dependencies are inferred from the claim text.